-
-
-
Sequence
- GIGKFⓍHSAⓍKFGKAFVGEIJNS
-
-
Original Sequence
- GIGKFLHSAKKFGKAFVGEIMNS
-
Source
- Synthetic construct
-
-
Biological Activity
- Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-
-
- Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.
-
Target Organism
-
- [Ref.31427820] Gram-positive bacteria: Staphyolococcus aureus ATCC 25923 (MIC = 25.00 μg/mL), Bacillus cereus ATCC 14579 (MIC = 17.68 μg/mL);
- Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 14.87 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC = 50.00 μg/mL)
-
Hemolytic Activity
-
- [Ref.31427820] It has 13.2% hemolysis against human red blood cells at 25 μg/mL.
-
Cytotoxicity
-
No cytotoxicity information found in the reference(s) presented
-
Linear/Cyclic
- Cyclic (Stapled)
-
N-terminal Modification
- Free
-
C-terminal Modification
- Amidation
-
Special Amino Acid and Stapling Position
- ①The Ⓧ (position: 6 and 10) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②The J (position: 21) in sequence is norlercine. ③Ⓧ (6) and Ⓧ (10) are cross-linked by hydrocarbon stapling.
-
-
Secondary Structure
- 14% α-helical content in 25-50 μM potassium phosphate solution.
-
Structure Description
- No other descriptive information about the structure found in the literature
-
- Literature 1
-
Title
- Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice
-
-
Reference
- Nat Biotechnol. 2019 Oct;37(10):1186-1197. doi: 10.1038/s41587-019-0222-z. Epub 2019 Aug 19.
-
Author
- Rida Mourtada, Henry D Herce, Daniel J Yin, Jamie A Moroco, Thomas E Wales, John R Engen, Loren D Walensky